Uveitis Clinical Trials

15 recruiting

Uveitis Trials at a Glance

25 actively recruiting trials for uveitis are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Lyon, Brescia, and Athens. Lead sponsors running uveitis studies include Hospices Civils de Lyon, The Cleveland Clinic, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About Uveitis Clinical Trials

Looking for clinical trials for Uveitis? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Uveitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Uveitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Phase 2

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

Active Non-anterior, Non-infectious Uveitis
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.40 enrolled1 locationNCT07552012
Recruiting

A Study of Uveitis in Children <18 Years of Age

Uveitis
Jaeb Center for Health Research300 enrolled4 locationsNCT07518134
Recruiting
Phase 2

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

Non-infectious Anterior Uveitis
Novaliq GmbH20 enrolled4 locationsNCT07285070
Recruiting
Phase 1Phase 2

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

Active Noninfectious Uveitis Affecting the Posterior Segment
Regeneron Pharmaceuticals72 enrolled4 locationsNCT07218770
Recruiting

RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age

Uveitis
Meyer Children's Hospital IRCCS290 enrolled19 locationsNCT06273748
Recruiting

Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)

Birdshot ChorioretinopathyPosterior Uveitis
Assistance Publique - Hôpitaux de Paris600 enrolled1 locationNCT05153057
Recruiting

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

Uveitis
The Cleveland Clinic1,500 enrolled1 locationNCT01746537
Recruiting

Genetics of Uveitis

UveitisInfectious Uveitis
The Cleveland Clinic1,500 enrolled1 locationNCT02357238
Recruiting

Metagenomics for Ocular Inflammation

InfectionUveitisAqueous Humor
Moorfields Eye Hospital NHS Foundation Trust36 enrolled1 locationNCT06974162
Recruiting
Early Phase 1

Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

Macular Edema (ME)Non Infectious Uveitis
University of Baghdad20 enrolled1 locationNCT07145008
Recruiting
Phase 3

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

UveitisUveitis, AnteriorUveitis, Posterior+1 more
Texas Retina Associates30 enrolled1 locationNCT05486468
Recruiting

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

SarcoidosisBirdshot ChorioretinitisBehcet Disease+5 more
Oregon Health and Science University125 enrolled1 locationNCT07065747
Recruiting

AutoInflammatory Disease Alliance Registry (AIDA)

UveitisStill DiseaseHereditary Autoinflammatory Diseases+5 more
University of Siena3,500 enrolled112 locationsNCT05200715
Recruiting
Phase 1

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

InflammationUveitis
Quan Dong Nguyen12 enrolled1 locationNCT06161415
Recruiting
Not Applicable

Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis

LymphomaNK-Cell LymphomaUveitis
Hospices Civils de Lyon60 enrolled2 locationsNCT05388838
Recruiting
Phase 2

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

Uveitis
American University of Beirut Medical Center32 enrolled1 locationNCT02706704
Recruiting

Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis

SpondylarthritisUveitis, Anterior
Marmara University100 enrolled1 locationNCT06720376
Recruiting

The Cohort Study of Uveitis Patients

Uveitis
Zhongshan Ophthalmic Center, Sun Yat-sen University600 enrolled1 locationNCT05727540
Recruiting
Phase 4

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Alimera Sciences25 enrolled6 locationsNCT06539481
Recruiting

A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

UveitisYUTIQ
Tianjin Medical University15 enrolled1 locationNCT05592717